CClinicalTrials.gg
CompletedNCT05483348Updated Aug 2, 2022

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection

An observational study in Uterine Bleeding, Treatment Failures and Prognostic Factors, sponsored by Naser Al-Husban. Completed at 1 site in Jordan. Open to female participants. Per ClinicalTrials.gov, last updated 2022-08-02.

Sponsored by Naser Al-Husban · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
95
Sex
Female
01

Study summary

To determine the predictive factors of endometrial ablation failure in the management of uterine bleeding.

Read the detailed description

This is a retrospective cohort study for women who have been treated with Thermal endometrial ablation due to uterine bleeding. The main purpose of this study is to demonstrate the possible risk factors associated with endometrial ablation failure causing patients to need subsequent gynecological procedures or undergoing hysterectomy for definitive treatment. Such efforts are made in order to anticipate the morbidity and mortality associated with patients in such conditions and to effectively stratify those patients to appropriate treatment techniques.

02

Conditions studied

  • Uterine Bleeding
  • Treatment Failures
  • Prognostic Factors

Browse trials for

Keywords

  • Endometrial Ablation Technique
  • Uterine Bleeding
  • Treatment Failures
  • Prognostic Factors
03

In context

Uterine Hemorrhage

156 studies on the registry are indexed under Uterine Hemorrhage; 19 are open to participants now.

This study's enrollment of 95 is below the median of 121 across 40 observational studies indexed under Uterine Hemorrhage.

Browse Uterine Hemorrhage studies →

Lead sponsor

This is the only study on the registry with Naser Al-Husban as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients who had attended the gynecology department at Jordan University Hospital.

Inclusion criteria

  • All patients who had their endometrial ablation at Jordan University Hospital.

Exclusion criteria

Exclusion Criteria:

  • Patients whose index ablation or subsequent re-intervention could not be confirmed in detailed operative reports were excluded
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
95 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients who had successful endometrial ablation

    Patients included in this group experienced abnormal uterine bleeding and underwent endometrial ablation. Successful ablation was defined as not undergoing subsequent gynecological procedures such as hysterectomy for any benign indication, D\&C or repeat ablation within 36 months after the endometrial ablation.

    Procedure: Endometrial Ablation

  • Patients who had unsuccessful endometrial ablation

    Patients included in this group experienced abnormal uterine bleeding and underwent endometrial ablation. Unsuccessful ablation was defined as undergoing subsequent gynecological procedures such as hysterectomy for any benign indication, D\&C or repeat ablation within 36 months after the endometrial ablation.

    Procedure: Endometrial Ablation · Procedure: Repeated gynecological procedure

Interventions

  • ProcedureEndometrial Ablation

    Thermal endometrial ablation

  • ProcedureRepeated gynecological procedure

    subsequent gynecological procedures such as hysterectomy for any benign indication, D\&C or repeat ablation.

06

What researchers measure

Primary outcomes

  1. Clinical Predictive factors of successful endometrial ablation

    the outcome of hysteroscopic endometrial ablation whether it was a failure or a success; failure was defined as persistent of heavy bleeding after the ablation.

    Time frame: from September 2016 through February 2022

Secondary outcomes

  1. The failure rate of endometrial ablation for uterine bleeding

    To find the failure rate of endometrial ablation that is done for uterine bleeding

    Time frame: from September 2016 through February 2022

  2. Subsequent gynecological procedures after failed ablation

    To find the subsequent gynecological procedures that patients with unsuccessful ablation had

    Time frame: from September 2016 through February 2022

07

Study locations

1 site
  • Jordan University Hospital
    Amman, Al Jubaiha 11942, Jordan
08

References and documents

Publications

  • Wortman M. Late-onset endometrial ablation failure. Case Rep Womens Health. 2017 Jul 12;15:11-28. doi: 10.1016/j.crwh.2017.07.001. eCollection 2017 Jul. PubMed 29593995 ↗
  • Riley KA, Davies MF, Harkins GJ. Characteristics of patients undergoing hysterectomy for failed endometrial ablation. JSLS. 2013 Oct-Dec;17(4):503-7. doi: 10.4293/108680813X13693422520602. PubMed 24398189 ↗
  • Smithling KR, Savella G, Raker CA, Matteson KA. Preoperative uterine bleeding pattern and risk of endometrial ablation failure. Am J Obstet Gynecol. 2014 Nov;211(5):556.e1-6. doi: 10.1016/j.ajog.2014.07.005. Epub 2014 Jul 11. PubMed 25019488 ↗
  • El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009 Jan;113(1):97-106. doi: 10.1097/AOG.0b013e31818f5a8d. Erratum In: Obstet Gynecol. 2010 Mar;115(3):663. PubMed 19104365 ↗
  • Gemer O, Kruchkovich J, Huerta M, Kapustian V, Kroll D, Anteby E. Perioperative predictors of successful hysteroscopic endometrial ablation. Gynecol Obstet Invest. 2007;63(4):205-8. doi: 10.1159/000097847. Epub 2006 Dec 7. PubMed 17159353 ↗
  • Shazly SA, Famuyide AO, El-Nashar SA, Breitkopf DM, Hopkins MR, Laughlin-Tommaso SK. Intraoperative Predictors of Long-term Outcomes After Radiofrequency Endometrial Ablation. J Minim Invasive Gynecol. 2016 May-Jun;23(4):582-9. doi: 10.1016/j.jmig.2016.02.002. Epub 2016 Feb 9. PubMed 26867699 ↗

Individual participant data

Plan to share: Undecided — It is not yet known if there will be a plan to make IPD available

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05483348
Lead sponsor
Naser Al-Husban
Responsible party
Naser Al-Husban (Assistant professor of obstetrics and gynecology, the university of jordan, University of Jordan) — Sponsor-investigator
First posted
Aug 2, 2022
Start date
Feb 17, 2022
Primary completion
Apr 28, 2022
Completion
Apr 28, 2022
Last update
Aug 2, 2022

Study contacts

Naser AL- Husban, MD
principal investigator · Assistant professor of obstetrics and gynecology, the university of jordan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion